DermTech, Inc.

NASDAQ:DMTK

0.094 (USD) • At close June 26, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Revenue 3.8453.9243.9153.983.4772.9943.5734.2333.7183.1653.033.1192.5242.1211.3620.8441.5571.5890.5650000000000000
Cost of Revenue 3.1323.4843.7433.9723.8213.353.6943.2733.5543.042.8982.6242.0021.7251.6081.4451.2031.2040.7790.93200.3310.6750.1580.0820.0970.1050.0230000
Gross Profit 0.7130.440.1720.008-0.344-0.356-0.1210.960.1640.1250.1320.4950.5220.396-0.246-0.6010.3540.385-0.214-0.9320-0.331-0.675-0.158-0.082-0.097-0.105-0.02300-0-0
Gross Profit Ratio 0.1850.1120.0440.002-0.099-0.119-0.0340.2270.0440.0390.0440.1590.2070.187-0.181-0.7120.2270.242-0.3790000000000000
Reseach & Development Expenses 3.2663.3483.5953.8874.4095.0975.7026.9156.3385.994.4263.5942.2511.9131.6180.8640.8970.650.7570000000000000
General & Administrative Expenses 10.1388.4228.26415.2211.8759.8288.8068.8788.5747.1646.1996.3015.1722.8432.9394.5293.5142.4193.2120000000000000
Selling & Marketing Expenses 7.8178.4228.12313.03315.41713.59814.63215.00115.44313.339.8267.9076.5125.1044.5943.4332.9442.4311.9760000000000000
SG&A 16.65516.84416.38728.25327.29223.42623.43823.87924.01720.49416.02514.20811.6847.9477.5337.9626.4584.855.1880000000000000
Other Expenses 00000000000000000-1.746-0.1310.9320.8140.3310.6750.1580.0820.0970.1050.0230000
Operating Expenses 19.92120.19219.98232.1431.70128.52329.1430.79430.35526.48420.45117.80213.9359.869.1518.8267.3555.55.9450.9320.8140.3310.6750.1580.0820.0970.1050.0230000
Operating Income -19.208-19.752-19.81-32.132-32.045-28.879-29.261-29.834-30.191-26.359-20.319-17.307-13.413-9.464-9.397-9.427-7.001-5.115-6.159-0.932-0.814-0.331-0.675-0.158-0.082-0.097-0.105-0.02300-0-0
Operating Income Ratio -4.996-5.034-5.06-8.073-9.216-9.646-8.189-7.048-8.12-8.328-6.706-5.549-5.314-4.462-6.899-11.169-4.496-3.219-10.9010000000000000
Total Other Income Expenses Net -0.8020.6610.0050.0060.7750.6560.4890.1050.0830.2620.1690.17-1.6890.0210.0090.01015.570.7970.0030.092-0.0010.016-0.048-0.01-0.0120.351-0.0240000
Income Before Tax -20.01-19.091-19.164-31.363-31.27-28.223-28.772-29.58-30.108-26.053-20.112-17.102-15.068-9.443-9.388-9.417-7.001-5.115-5.726-0.139-0.0050.5040.0020.4440.390.2520.246-0.03200-0-0
Income Before Tax Ratio -5.204-4.865-4.895-7.88-8.993-9.427-8.053-6.988-8.098-8.232-6.638-5.483-5.97-4.452-6.893-11.158-4.496-3.219-10.1350000000000000
Income Tax Expense 02.19-0.646-0.769-0.775-1.312-0.978-0.254-0.166-0.612-0.414-0.413.31-0.042-0.018-0.0202.399-0.797-0.793-0.809-0.835-0.677-0.602-0.472-0.349-0.3510.0090000
Net Income -20.01-19.091-19.164-31.363-30.495-26.911-27.794-29.58-29.942-26.053-20.112-17.102-15.068-9.443-9.388-9.417-7.001-5.115-5.726-0.139-0.0050.5040.0020.4440.390.2520.246-0.03200-0-0
Net Income Ratio -5.204-4.865-4.895-7.88-8.77-8.988-7.779-6.988-8.053-8.232-6.638-5.483-5.97-4.452-6.893-11.158-4.496-3.219-10.1350000000000000
EPS -0.58-0.56-0.57-0.99-1-0.89-0.93-0.99-1-0.88-0.68-0.59-0.55-0.35-0.5-0.58-0.53-0.39-0.8-0.053-0.002-0.1-0.24-0.040.34-0.02-0.04-0.0170000
EPS Diluted -0.58-0.56-0.57-0.99-1-0.89-0.92-0.99-1-0.88-0.68-0.59-0.55-0.35-0.5-0.58-0.53-0.39-0.8-0.053-0.002-0.1-0.24-0.040.34-0.02-0.04-0.0040000
EBITDA -17.802-18.406-18.467-30.659-32.038-28.894-28.165-28.871-29.401-26.621-19.326-17.269-11.531-9.284-9.239-9.339-6.941-5.115-6.29-0.935-0.906-0.33-0.69-0.11-0.072-0.085-0.1050.00100-0-0
EBITDA Ratio -4.63-4.691-4.717-7.703-9.214-9.651-7.883-6.82-7.908-8.411-6.378-5.537-4.569-4.377-6.783-11.065-4.458-3.219-11.1330000000000000